Is Uber Stock a Buy, Sell or Hold?
Uber (NYSE:UBER) has been through quite a ride over the…
Sell
32
OGI Quote, Financials, Valuation and Earnings
Last price:
$1.07
Seasonality move
:
-11.31%
Day range:
$1.03 - $1.09
52-week range:
$0.85 - $2.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.82x
P/B ratio:
0.58x
Volume:
662.7K
Avg. volume:
572.6K
1-year change:
-41.53%
Market cap:
$131.3M
Revenue:
$117.5M
EPS (TTM):
-$0.41
Analysts' Opinion
-
Consensus RatingOrganigram Global has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Organigram Global has an estimated upside of 213.46% from its current price of $1.07.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.07.
Fair Value
-
According to the consensus of 5 analysts, Organigram Global has 213.46% upside to fair value with a price target of -- per share.
OGI vs. S&P 500
-
Over the past 5 trading days, Organigram Global has overperformed the S&P 500 by 10.71% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Organigram Global does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Organigram Global has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Organigram Global reported revenues of $30.4M.
Earnings Growth
-
Organigram Global has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Organigram Global reported earnings per share of -$0.14.
Enterprise value:
98.7M
EV / Invested capital:
--
Price / LTM sales:
0.82x
EV / EBIT:
--
EV / Revenue:
0.82x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-10.13x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$39.8M
Return On Assets:
-14.04%
Net Income Margin (TTM):
-31.67%
Return On Equity:
-18.03%
Return On Invested Capital:
-18.02%
Operating Margin:
-15.92%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | $112.3M | $121.1M | $26.8M | $30.4M | |
| Gross Profit | -- | $26.4M | $39.8M | $4.9M | $9.8M | |
| Operating Income | -- | -$37.6M | -$19.4M | -$11.7M | -$4.8M | |
| EBITDA | -- | -$153.8M | -$10.5M | -$9.5M | -$2.4M | |
| Diluted EPS | -- | -$0.66 | -$0.41 | -$0.14 | -$0.14 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $120.8M | $161.3M | |
| Total Assets | -- | -- | -- | $225.4M | $333.9M | |
| Current Liabilities | -- | -- | -- | $28.2M | $48M | |
| Total Liabilities | -- | -- | -- | $31M | $108.4M | |
| Total Equity | -- | -- | -- | $194.4M | $225.5M | |
| Total Debt | -- | -- | -- | $102.5K | $48.8K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$10.4M | -$5.8M | $5.6M | -$3M | |
| Cash From Investing | -- | $5.1M | -$72.6M | $305.6K | -$43.8M | |
| Cash From Financing | -- | -$533.4K | $79.2M | -$111.7K | -$143.9K | |
| Free Cash Flow | -- | -$28.5M | -$9.7M | $4.5M | -$4.1M | |
OGI
Sector
Market Cap
$131.3M
$35M
Price % of 52-Week High
47.93%
41.88%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.91%
1-Year Price Total Return
-44.68%
-43.29%
Beta (5-Year)
1.095
0.743
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.00
200-day SMA
Sell
Level
$1.54
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$1.02
Relative Strength Index (RSI14)
Buy
Level
52.89
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-26.9231
50-day SMA
Sell
Level
$1.15
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2766)
Buy
CA Score
(Annual)
Level (0.7161)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.1787)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Stock Forecast FAQ
In the current month, OGI has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The OGI average analyst price target in the past 3 months is --.
-
Where Will Organigram Global Stock Be In 1 Year?
According to analysts, the consensus estimate is that Organigram Global share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Organigram Global?
Analysts are divided on their view about Organigram Global share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Organigram Global is a Sell and believe this share price will drop from its current level to --.
-
What Is Organigram Global's Price Target?
The price target for Organigram Global over the next 1-year time period is forecast to be -- according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is OGI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Organigram Global is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OGI?
You can purchase shares of Organigram Global via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Organigram Global shares.
-
What Is The Organigram Global Share Price Today?
Organigram Global was last trading at $1.07 per share. This represents the most recent stock quote for Organigram Global. Yesterday, Organigram Global closed at $1.07 per share.
-
How To Buy Organigram Global Stock Online?
In order to purchase Organigram Global stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Micron a Good Stock to Buy Now?
Like most of its peers in the semiconductor industry, Micron…
Is Uber Finally on the Path to Consistent Profitability?
After posting massive losses quarter after quarter for years, Uber…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 36x
Alerts
Sell
32
MAN alert for Apr 18
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 18
Global Payments [GPN] is down 17.44% over the past day.
Buy
51
CAR alert for Apr 18
Avis Budget Group [CAR] is up 16.54% over the past day.
